気道陽圧装置の市場規模、シェア、成長分析：製品タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

気道陽圧装置 2023年の市場規模は22億7,000万米ドルで、2024年の23億9,000万米ドルから2032年には35億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.2%で推移する見通しです。

世界の気道陽圧（PAP）装置市場は、睡眠時無呼吸症候群のような睡眠関連の呼吸障害に対する意識の高まりと診断に後押しされ、一貫した成長を遂げています。これらの疾患は健康全般に大きな影響を与えるため、非侵襲的で呼吸を強化する持続的気道陽圧（CPAP）や二段階陽圧（BiPAP）装置などの効果的な治療オプションに対する需要が高まっています。主な成長促進要因としては、ヘルスケア支出の増加、快適性を向上させる技術の進歩、睡眠障害を起こしやすい高齢化社会などが挙げられます。メーカー、ヘルスケアプロバイダー、研究機関の協力体制が技術革新を促進しています。しかし、患者のアドヒアランス、コスト懸念、規制上のハードルなどの課題により、業界の調整が必要となっており、各社は製品の改良と流通の強化を迫られる一方、PAP療法の受容を促進するための教育普及活動に投資しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析
• 技術分析

気道陽圧装置市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 持続陽圧呼吸療法装置（CPAP）
• 自動陽圧呼吸装置（APAP）
• 二相性陽圧呼吸装置（BiPAP）

気道陽圧装置市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 閉塞性睡眠時無呼吸
• 呼吸不全
• 慢性閉塞性肺疾患（COPD）
• その他

気道陽圧装置市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 在宅ヘルスケア
• 睡眠研究室とクリニック

気道陽圧装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• ResMed Inc.（USA）
• Koninklijke Philips N.V.（Netherlands）
• Fisher & Paykel Healthcare Corporation Limited（New Zealand）
• DeVilbiss Healthcare LLC（USA）
• Drive Medical（USA）
• 3B Medical, Inc.（USA）
• Apex Medical Corp.（Taiwan）
• BMC Medical Co., Ltd.（China）
• Somnetics International, Inc.（USA）
• Invacare Corporation（USA）
• Medtronic plc（Ireland）
• Vyaire Medical, Inc.（USA）
• Compumedics Limited（Australia）
• Lowenstein Medical Innovation GmbH & Co. KG（Germany）
• Teijin Pharma Limited（Japan）
• Nihon Kohden Corporation（Japan）
• Itamar Medical Ltd.（Israel）
• Circadiance LLC（USA）
• Breas Medical AB（Sweden）
• Weinmann Emergency Medical Technology GmbH+Co. KG（Germany）

結論と提言

Positive Airway Pressure Devices Market size was valued at USD 2.27 billion in 2023 and is poised to grow from USD 2.39 billion in 2024 to USD 3.58 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global Positive Airway Pressure (PAP) device market is experiencing consistent growth fueled by heightened awareness and diagnosis of sleep-related breathing disorders like sleep apnea. These conditions significantly impact overall health, increasing the demand for effective treatment options such as Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, which are non-invasive and enhance breathing. Key growth drivers include rising healthcare expenditures, technological advancements improving comfort, and an aging population more prone to sleep disorders. Collaborative efforts among manufacturers, healthcare providers, and research institutions are fostering innovation. However, challenges like patient adherence, cost concerns, and regulatory hurdles necessitate industry adjustments, compelling companies to refine their products and enhance distribution while investing in educational outreach to promote acceptance of PAP therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positive Airway Pressure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positive Airway Pressure Devices Market Segments Analysis

Global Positive Airway Pressure Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Continuous Positive Airway Pressure (CPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices and Bi-level Positive Airway Pressure (BiPAP) Devices. Based on Application, the market is segmented into Obstructive Sleep Apnea, Respiratory Failures, Chronic Obstructive Pulmonary Disease (COPD) and Others. Based on End User, the market is segmented into Hospitals, Home Healthcare and Sleep Laboratories & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positive Airway Pressure Devices Market

The rising global incidence of sleep disorders significantly influences the growth of the positive airway pressure (PAP) devices market. These devices are essential for treating conditions such as obstructive sleep apnea (OSA), as they provide an effective primary solution for managing these ailments. By promoting a clear airway during sleep, PAP therapy effectively tackles the root causes of these disorders. As the prevalence of sleep disorders continues to climb, the demand for PAP devices is projected to increase, positioning them as a crucial driver for market expansion in the coming years. Thus, the correlation between sleep disorder rates and PAP device demand underscores a positive market outlook.

Restraints in the Positive Airway Pressure Devices Market

Although Positive Airway Pressure (PAP) devices are highly effective for treating sleep-related breathing disorders, including sleep apnea, many patients face challenges in using them consistently as directed. This non-compliance is often the result of discomfort, poorly fitting masks, and feelings of claustrophobia, all of which can lead to diminished motivation to adhere to therapy. Additionally, a lack of understanding regarding the long-term health benefits associated with PAP use further contributes to this issue. Addressing these adherence barriers is crucial for maximizing the effectiveness of PAP devices and achieving positive health outcomes; however, patient compliance remains a significant obstacle for market growth and success.

Market Trends of the Positive Airway Pressure Devices Market

The Positive Airway Pressure (PAP) devices market is witnessing a significant shift towards remote monitoring and telehealth solutions, driven by advancements in healthcare technology. Manufacturers are increasingly incorporating connectivity features into PAP devices, enabling seamless transmission of therapy data from patients to healthcare providers. This innovation facilitates real-time feedback, improving patient adherence to treatment plans and enhancing overall therapy management. As healthcare increasingly embraces digital solutions, this trend is poised to reshape the PAP devices market, fostering greater patient engagement and optimizing health outcomes. The continued integration of telehealth capabilities is expected to propel market growth well into the future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Positive Airway Pressure Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Continuous Positive Airway Pressure (CPAP) Devices
• Automatic Positive Airway Pressure (APAP) Devices
• Bi-level Positive Airway Pressure (BiPAP) Devices

Global Positive Airway Pressure Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Obstructive Sleep Apnea
• Respiratory Failures
• Chronic Obstructive Pulmonary Disease (COPD)
• Others

Global Positive Airway Pressure Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Home Healthcare
• Sleep Laboratories & Clinics

Global Positive Airway Pressure Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3B Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMC Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Somnetics International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lowenstein Medical Innovation GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Pharma Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Itamar Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circadiance LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Breas Medical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weinmann Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations